Yages Singh

Yages Singh

Auto-generated profile, based on publicly available information

Yages Singh

South African Medical Research Council

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2023 in JMIR Research Protocols
Verified
Journal Article
Open access
TCTerusha Chetty
Terusha Chetty
YSYages Singh
Yages Singh
WOWillem Odendaal
Willem Odendaal
SMSolange Mianda
Solange Mianda
NANada Abdelatif
Nada Abdelatif
AGAmeena Goga
Ameena Goga
Background: The COVID-19 pandemic undermined gains in reducing maternal and perinatal mortality in South Africa. The Mphatlalatsane Initiative is a health system intervention to reduce mortality and morbidity in women and newborns to desired levels. Objective: Our evaluation aims to determine the effect of various exposures, including the COVID-19 pandemic, and a system-level, complex, patient-centered quality improvement (QI) intervention (the Mphatlalatsane Initiative) on maternal and neonatal health services at 21 selected South African facilities. The objectives are to determine whether Mphatlalatsane reduces the institutional maternal mortality ratio, neonatal mortality rate, and stillbirth rate (objective 1) and improves patients’ experiences (objective 2) and quality of care (objective 3). Objective 4 assesses the contextual and implementation process factors, including the COVID-19 pandemic, that shape Mphatlalatsane uptake and variation. Methods: This study is an implementation science type 2 hybrid effectiveness, controlled before-and-after design with quantitative and qualitative components. The Mphatlalatsane intervention commenced at the end of 2019. For objective 1, intervention and control facility-level data from the District Health Information System are compared for changes in institutional maternal and neonatal mortality and stillbirth rates and associations with QI, the COVID-19 pandemic, and both. This first analysis includes data from 18 facilities, regardless of their allocation to intervention or comparison, to obtain a general idea of the effect of the COVID-19 pandemic. For objectives 2 to 3, data collectors abstract data from maternal and neonatal records, interview participants, and conduct neonatal facility assessments. For objective 4, interviews, program documentation, surveys, and observations are used to assess how contextual factors at the macro-, meso-, and microlevels explain variation in intervention uptake and outcome. The intervention dose is measured at the microlevel only in the intervention facilities. The study assesses the Mphatlalatsane Initiative from 2020 to 2022. Results: From preliminary analysis, across the 3 provinces, maternal and neonatal deaths increased during the COVID-19 pandemic, whereas stillbirths remained unchanged. Maternal satisfaction with quality of care was >90%. The COVID-19 pandemic severely disrupted the QI teams functioning. However, the QI teams regained their pre–COVID-19 momentum by adapting the QI model, with advisers providing mentoring and support. Variation in adoption at the mesolevel was related to stable and motivated leadership (particularly at the facility level), poor integration into routine processes, and buy-in from senior district managers who were affected by competing priorities. Varying referral and specialist outreach systems, staff availability and development, and service delivery infrastructure are plausible factors in variable outcomes. Conclusions: Few evaluations rigorously evaluated the effect of health system interventions on improving health services and outcomes. Results will inform the scaling up of successful intervention components and strategies to mitigate the effects of the COVID-19 pandemic or similar emerging epidemics on maternal and neonatal mortality. International Registered Report Identifier (IRRID): DERR1-10.2196/42041

26 October 2026 in South African Health Review
Verified
Journal Article
Open access
PDF file
WOWillem Odendaal
Willem Odendaal
AGAmeena Goga
Ameena Goga
MTMark Tomlinson
Mark Tomlinson
HSHelen Schneider
Helen Schneider
YSYages Singh
Yages Singh
XHXanthe Hunt
Xanthe Hunt
Aim: This evaluation identifies the factors that shaped the performance of quality improvement teams for maternal and neonatal health, before, during, and after the COVID-19 pandemic. Method: A longitudinal, qualitative evaluation of a National Department of Health quality improvement (QI) programme called Mphatlalatsane was undertaken. The programme adopts a plan-do-study-act cycle to identify and implement change ideas that support QI, through QI teams comprising existing facility staff. Mphatlalatsane was implemented in 21 facilities across three provinces, between 2018–2022. Fifteen teams were purposively selected for this evaluation, ranging from primary health care clinics to regional hospitals. The evaluation comprised of interviews with QI team leaders and members undertaken at three time points, monthly debriefings with the technical advisors, review of programme documentation, and observing Mphatlalatsane management meetings. Data were thematically analysed. Findings: The COVID-19 pandemic resulted in teams introducing major, yet effective, adaptations to the QI methodology. Six teams were assessed as performing well in conducting activities to improve service delivery. Those teams had advisors who were technically skilled, leaders and members with an aptitude for QI methods, and support from facility management. Team performance was shaped by the interplay between advisor, leader, members, and prevailing work culture in the existing facility service teams. Conclusion: Healthcare workers in well performing teams successfully implemented and sustained QI, despite the COVID-19 pandemic challenges. Supporting a QI team to enthusiastically and sustainably use the methodology, requires acknowledging that the advisor, leader, and members create a microsystem that becomes more than the sum of its parts. QI success lies in the interplay among elements in this microsystem, and not in the absence or presence of individual elements.

19 August 2022 in JMIR Preprints
Verified
Preprint
Open access
TCTerusha Chetty
Terusha Chetty
YSYages Singh
Yages Singh
WOWillem Odendaal
Willem Odendaal
SMSolange Mianda
Solange Mianda
NANada Abdelatif
Nada Abdelatif
AGAmeena Goga
Ameena Goga
BACKGROUND The COVID-19 pandemic undermined gains in reducing maternal and perinatal mortality in South Africa. The Mphatlalatsane Initiative is a health system intervention to reduce mortality and morbidity in women and newborns to desired levels. OBJECTIVE Our evaluation aims to determine the effect of various exposures, including the COVID-19 pandemic, and a system-level, complex, patient-centered quality improvement (QI) intervention (the Mphatlalatsane Initiative) on maternal and neonatal health services at 21 selected South African facilities. The objectives are to determine whether Mphatlalatsane reduces the institutional maternal mortality ratio, neonatal mortality rate, and stillbirth rate (objective 1) and improves patients’ experiences (objective 2) and quality of care (objective 3). Objective 4 assesses the contextual and implementation process factors, including the COVID-19 pandemic, that shape Mphatlalatsane uptake and variation. METHODS This study is an implementation science type 2 hybrid effectiveness, controlled before-and-after design with quantitative and qualitative components. The Mphatlalatsane intervention commenced at the end of 2019. For objective 1, intervention and control facility-level data from the District Health Information System are compared for changes in institutional maternal and neonatal mortality and stillbirth rates and associations with QI, the COVID-19 pandemic, and both. This first analysis includes data from 18 facilities, regardless of their allocation to intervention or comparison, to obtain a general idea of the effect of the COVID-19 pandemic. For objectives 2 to 3, data collectors abstract data from maternal and neonatal records, interview participants, and conduct neonatal facility assessments. For objective 4, interviews, program documentation, surveys, and observations are used to assess how contextual factors at the macro-, meso-, and microlevels explain variation in intervention uptake and outcome. The intervention dose is measured at the microlevel only in the intervention facilities. The study assesses the Mphatlalatsane Initiative from 2020 to 2022. RESULTS From preliminary analysis, across the 3 provinces, maternal and neonatal deaths increased during the COVID-19 pandemic, whereas stillbirths remained unchanged. Maternal satisfaction with quality of care was >90%. The COVID-19 pandemic severely disrupted the QI teams functioning. However, the QI teams regained their pre–COVID-19 momentum by adapting the QI model, with advisers providing mentoring and support. Variation in adoption at the mesolevel was related to stable and motivated leadership (particularly at the facility level), poor integration into routine processes, and buy-in from senior district managers who were affected by competing priorities. Varying referral and specialist outreach systems, staff availability and development, and service delivery infrastructure are plausible factors in variable outcomes. CONCLUSIONS Few evaluations rigorously evaluated the effect of health system interventions on improving health services and outcomes. Results will inform the scaling up of successful intervention components and strategies to mitigate the effects of the COVID-19 pandemic or similar emerging epidemics on maternal and neonatal mortality. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/42041